🚨Please join our next Journal Club on Friday 15th March 10-11am (EDT), where
@AntoniosDouros
will present: “Time-varying exposure definition in studying drug-drug interaction"
Followed by discussion and Q&A
Register here: https://t.co/N9XaYN3xFn
At the SOGC's medical student's program, they learned about IUD insertion, suturing, laparoscopy, hysteroscopy and clinical research in OBGYN.
#SOGC#medicallearning
Congrats to #JennyDimakos for the first place at the #DDI Spotlight Poster Session yesterday! Jenny presented the results of our study on the risk of hypoglycemia with sulfonylureas and beta-blockers @IntPharmacoEpi@ispesig_ddi#ICPE22@LDI_ILD
Very excited that our @CIHR_IRSC funded study on the concomitant use of sulfonylureas and warfarin and the risk of severe hypoglycemia, led by #JennyDimakos, was recently published in @DiabetesCareADA! A short thread follows: 1/n https://t.co/mZuc1ebk52 @ADA_Pubs@LDI_ILD
A study showed that beta-blockers were associated w/ a 50% increase in the risk of severe hypoglycemia when used concurrently w/ sulfonylureas. Cardioselectivity of beta-blockers did not appear to play a major role in this regard. @ADA_Pubs
Read Here➡️https://t.co/FqwzAWnGOb
More on SUs
β-blockers associated with ⬆️risk of severe hypoglycemia when used concurrently with sulfonylureas.
β-blocker cardioselectivity did not seem to play a major role in this regard.
https://t.co/GhZqf8ghBQ